Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention. - Wikidata - wikimedia - TriplyDB

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

http://www.wikidata.org/entity/Q37451509

about

Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.Elinogrel: pharmacological principles, preclinical and early phase clinical testing.

P2860

Q37797795-059EEE91-DC80-4E79-84D4-6569FEAF91B8 Q38087381-EBB201D1-F6D2-49AD-A419-32ABB41402DB Q42978644-B6E163E3-D2E7-42CE-B177-54B0A5FD73E2

P2860

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

http://www.wikidata.org/entity/Q37451509

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prasugrel in acute coronary sy ...... taneous coronary intervention.

@en

Prasugrel in acute coronary sy ...... taneous coronary intervention.

@nl

type

label

Prasugrel in acute coronary sy ...... taneous coronary intervention.

@en

Prasugrel in acute coronary sy ...... taneous coronary intervention.

@nl

prefLabel

Prasugrel in acute coronary sy ...... taneous coronary intervention.

@en

Prasugrel in acute coronary sy ...... taneous coronary intervention.

@nl

P1433

Q37451509-3E33C28D-C1D8-4E50-8319-60032648B897

P1476

Q37451509-94998AE0-C23C-4127-BDA7-1DE2739FE4FE

P2093

Q37451509-0D368572-6CDA-437E-9417-C2CD82F3A97C

P2860

Q37451509-0620CB9E-4D4F-4A75-8713-5578D4B6A00D

Q37451509-24344758-6BCC-4C83-A7DB-917E1ACA9D40

Q37451509-32A684F6-CC24-41EF-BD4D-DB623370BD67

Q37451509-3813BD41-D5E3-4EA8-9260-650F4EC72802

Q37451509-38780F9E-7DF0-4AA8-8712-2CEEAB4483C1

Q37451509-3F682AF6-3B92-40E5-8BC2-67DBD7BB4BCF

Q37451509-5A56B7A2-126A-4440-833B-4BDC058DB219

Q37451509-624BBE72-D584-4858-A33A-AE796B29A3FF

Q37451509-6444FCEA-AE67-413F-97DB-9A3BACA5C124

Q37451509-64AFD683-0137-4240-ADA7-C9F07FAB00C2

P304

Q37451509-1F9377F9-98C9-4CF1-8559-C2D0A9FBCDCA

P31

Q37451509-6B8EED3E-851E-4982-94F6-8E2A1219E62E

P356

Q37451509-E75B32C6-476E-4E7A-A074-2ACF30AB811B

P433

Q37451509-A048768D-D3E9-4358-9019-CA725BE41153

P478

Q37451509-096C2251-A594-4E2A-8B71-3EB0A348B376

P50

Q37451509-0A67196A-9745-4DBA-9487-52E7F16F0BC6

Q37451509-FE3F51CA-81E4-4012-A325-5DFAE609B6F4

P577

Q37451509-D61F25B2-43F2-45A7-AB2A-42A11B311878

P698

Q37451509-9686195A-6D05-4AAD-915D-358C22A1B94F

P356

P1433

Expert Review of Cardiovascular Therapy

P1476

Prasugrel in acute coronary sy ...... utaneous coronary intervention

@en

P2093

Dominick J Angiolillo

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment

Platelet activation in type 2 diabetes mellitus

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

P304

361-369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.09.4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

José L Ferreiro

Piera Capranzano

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19379060

http://www.w3.org/2001/XMLSchema#string